Movement Alert|Stryker Falls 6.41% in Regular Trading, HCA Healthcare Disappointing Outlook Drags Medical Device Sector

Market Focus07-14

On July 14, Stryker fell 6.41% in regular trading, trading at $310.00 USD/share, with turnover of $341 million.

On the news front, HCA Healthcare issued a disappointing earnings outlook, sparking concerns over slowing demand across the healthcare industry. Stryker, as a leading medical device company, was notably dragged down by the sector-wide selloff. On the same day, Goldman Sachs lowered its price target on Stryker from $363 to $339 while maintaining a neutral rating, adding further selling pressure. The analyst consensus mean price target stands at $387.44 with an average overweight rating.

Within the Health Care Equipment sector, the broad decline was pronounced. GE Healthcare Technologies fell 5.79%, Intuitive Surgical dropped 4.65%, Medtronic declined 4.64%, Boston Scientific lost 4.59%, and Abbott Laboratories fell 3.0%, reflecting significant contagion effects from the industry-level headwind.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment